Certara QSP Designer Technology
User-driven, graphical workspace to optimize collaboration for all stakeholders
CertaraOctober 25, 2023
Advancing Rectal Drug Delivery: A Breakthrough in Physiologically Based Pharmacokinetic Modeling
This blog explains how Certara’s Simcyp team developed and tested a model in the Simcyp…
CertaraOctober 20, 2023
RAPS Sponsored Webcast: Leveraging Today’s Technology to Accelerate Submissions: Real Life Examples and Lessons Learned
As the drug development industry strives to accelerate submission timelines and improve patient access to…
CertaraOctober 18, 2023
AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
The development of new drugs for rare diseases is a challenging process due to small…
CertaraOctober 12, 2023
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…
CertaraOctober 11, 2023
Regulatory initiatives for artificial intelligence applications: Regulatory writing implications
Medical Writing | Volume 32, Issue 3 - Artificial Intelligence and Machine LearningAuthor: Anjana Bose…
CertaraOctober 11, 2023
Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions
Formedix ryze cloud based clinical metadata repository and SDTM automation suite and Certara Pinnacle 21…
CertaraOctober 10, 2023
Do the Scale-up & Post approval Changes (SUPAC) Guidance Documents Still Apply to Drug Developers?
Do you remember the 1990s? The Soviet Union fell, Friends was the most popular TV…
CertaraOctober 6, 2023
Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform
Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October…
CertaraOctober 5, 2023
